SW
Simon White
Director Of Investor Relations at Paradigm Biopharmaceuticals
View Simon's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Director Of Investor Relations
2020 - Present · 5 years
DELCOR Family Office
Corporate Advisor
2018 - 2020 · 2 years
Sequoia Wealth Management
Institutional Advisor
2017 - 2018 · 1 years
Company Details
11-50 Employees
Paradigm’s (ASX:PAR) immediate commercial focus is the development of pentosan polysulfate sodium (PPS) for the treatment of osteoarthritis (OA). This is a global unmet need and we have advanced to phase 3 trials in the space. Addressing all aspects of the disease: inflammation, pain, and regeneration, the non-opioid PPS has genuine disease-modifying potential.
Year Founded
2014
Social Media
Linkedin
Industry
Pharmaceutical Manufacturing, Antiseptics and antibacterial preparations, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Pharmaceutical preparations NES, Pharmaceutical preparations for the central and autonomic nervous system and anaesthetics, Pharmaceutical preparations for the cardiovascular system
HQ Location
500 collins
L2 517 Flinders Lane
Melbourne, Victoria 3000, AU
Keywords
--
Contact Details
- Email AddressS**@paradigmbiopharma.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
You May Also Interested In
Find verified contacts of Simon White in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.